China Biotech Services and WeDoctor Announce Strategic Partnership to Advance Integrated Health Management Solutions

VCBeat (WeChat ID: vcbeat) has learned that on June 3, China Biotech Services Holdings Limited (08037), a company listed on the Hong Kong Stock Exchange, announced that its subsidiary, Jinnuocai International Health Management Company, will enter into a comprehensive cooperation with WeDoctor, an internationally leading healthcare technology platform.

The signing of this collaboration marks the launch of a new model of cooperation between medical institutions in the two regions. By leveraging their complementary strengths, both parties will provide more accessible, precise, effective, and convenient health management services in areas such as antibody testing, vaccination, and precision health screenings, thereby moving beyond conventional preoperative testing methods.

Zheng Yuling, Chief Operating Officer of WeDoctor Greater Bay Area;

Yao Yi and Liu Xiaolin, Co-Chairmen and Executive Directors of China Biotech Services Holdings Limited

Amidst the surge in demand for health services, the market calls for advanced technologies and more accessible healthcare solutions. Established in 1994, Genos International Health Management Center currently operates three clinics in Hong Kong, primarily providing preventive medicine services tailored to individuals of all ages and genders. The center boasts a team of professional medical resources, including radiologists, radiologic technologists, medical laboratory technologists, and nurses. All laboratory tests are conducted by professional and experienced medical laboratory technologists. Equipped with precision instruments and fully computerized operations, the laboratory is under the supervision and advisory of resident radiologists and pathologists. Test reports are signed by registered Class I Medical Laboratory Technologists to ensure accuracy and efficiency.

Jinnuosai International Health Management Center Hong Kong Clinic

WeDoctor originated from Guahao.com, which was established in 2010. With the mission of “making medical care accessible and health manageable,” it provides users with a new model of healthcare services that integrates “online and offline” as well as “general practice and specialty care.” As of March 2019, WeDoctor had connected more than 2,700 key hospitals and 280,000 doctors across 30 provinces and municipalities in China, establishing a healthcare resource supply system that combines online and offline services and integrates general practice with specialty care. The number of real-name registered users exceeded 190 million, with cumulative service encounters surpassing 810 million.

WeDoctor has also established a significant presence in the Guangdong-Hong Kong-Macao Greater Bay Area. In November 2018, to promote innovation and integration in healthcare services within the region, the WeDoctor Greater Bay Area Collaboration Platform was officially launched in Hong Kong, with Dr. Wu Ting-suk, Standing Committee Member of the National Committee of the Chinese People's Political Consultative Conference and former Chairman of the Hospital Authority of Hong Kong, serving as the Platform’s Chairman. To date, the platform has connected more than 80 hospitals and clinics across 21 prefecture-level cities in Guangdong Province and the Hong Kong Special Administrative Region, along with over 10,000 physicians, creating a high-quality health ecosystem for the 70 million residents of the Greater Bay Area that delivers “90 seconds online, 90 minutes offline.”

Hong Kong boasts a globally leading healthcare system, with its medical technology standards and healthcare safety quality consistently at the forefront worldwide. Under the Greater Bay Area policy framework, both sides are proactively seeking collaboration to extend medical services from the mainland to Hong Kong. The introduction of these services into the Hong Kong healthcare market represents an innovative integration of the mainland’s “Internet + Healthcare” family doctor-style services with the “Hong Kong-style medical model,” holding significant milestone importance.